Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Pancreatitis

Free Subscription Articles published in J Gastroenterol Retrieve available abstracts of 40 articles: HTML format

Single Articles

September 2025
1. WANG X, Zhang Y, Li A, Zhou C, et al
   STYK1 as a targetable vulnerability enhances the efficacy of anti-PD-L1 therapy in pancreatic cancer.
   J Gastroenterol. 2025 Sep 19. doi: 10.1007/s00535-025-02291.
   PubMed     Abstract available
   
   
   July 2025
2. TANAKA Y, Masamune A, Matsumoto R, Takikawa T, et al
   Nationwide epidemiological survey of acute pancreatitis in Japan, 2021: the impact of the COVID-19 pandemic and revised clinical guidelines.
   J Gastroenterol. 2025 Jul 31. doi: 10.1007/s00535-025-02284.
   PubMed     Abstract available
   
   
   
3. EMORI T, Itonaga M, Ashida R, Ishihara T, et al
   Impact of sarcopenia and changes in skeletal muscle mass on prognosis of patients with pancreatic ductal adenocarcinoma receiving chemotherapy with first-line gemcitabine and nab-paclitaxel: a prospective study.
   J Gastroenterol. 2025 Jul 17. doi: 10.1007/s00535-025-02283.
   PubMed     Abstract available
   
   
   June 2025
4. LIU S, Su J, Zhao H, Bai R, et al
   Correction: Identification of novel plasma proteins as promising noninvasive biomarker for early diagnosis and surveillance of pancreatic ductal adenocarcinoma.
   J Gastroenterol. 2025 Jun 27. doi: 10.1007/s00535-025-02274.
   PubMed    
   
   
   
5. LEI S, Zhang Z, Zeng Z, Cao W, et al
   aGenome-scale activation screen reveals lncRNA HNF1A-AS1 promotes pancreatic cancer metastasis through interacting with U2SURP to increase CD44 alternative splicing.
   J Gastroenterol. 2025 Jun 15. doi: 10.1007/s00535-025-02272.
   PubMed     Abstract available
   
   
   May 2025
6. NISHIWADA S, Nakamura K, Ozu N, Terai T, et al
   An axon guidance-related microRNA panel identifies perivascular plexus local recurrence following curative surgery in patients with pancreatic cancer.
   J Gastroenterol. 2025 May 10. doi: 10.1007/s00535-025-02260.
   PubMed     Abstract available
   
   
   
7. ENDO G, Ishigaki K, Nakai Y, Nishio H, et al
   Factors associated with actionable gene aberrations in pancreatic cancer based on the C-CAT database.
   J Gastroenterol. 2025 May 2. doi: 10.1007/s00535-025-02253.
   PubMed     Abstract available
   
   
   
8. MANAKA T, Takikawa T, Tarasawa K, Kikuta K, et al
   Current status and trends in ERCP and post-ERCP pancreatitis in Japan: a nationwide observational study.
   J Gastroenterol. 2025 May 2. doi: 10.1007/s00535-025-02254.
   PubMed     Abstract available
   
   
   April 2025
9. LIU S, Su J, Zhao H, Bai R, et al
   Identification of novel plasma proteins as promising noninvasive biomarker for early diagnosis and surveillance of pancreatic ductal adenocarcinoma.
   J Gastroenterol. 2025 Apr 26. doi: 10.1007/s00535-025-02252.
   PubMed     Abstract available
   
   
   March 2025
10. WU Z, Yang J, Ma Z, Chen Y, et al
    Nuclear magnetic resonance-based metabolomics and risk of pancreatic cancer: a prospective analysis in the UK Biobank.
    J Gastroenterol. 2025 Mar 12. doi: 10.1007/s00535-025-02237.
    PubMed     Abstract available
    
    
    January 2025
11. ABU-SERIE MM, Gutierrez-Garcia AK, Enman M, Vaish U, et al
    Ferroptosis- and stemness inhibition-mediated therapeutic potency of ferrous oxide nanoparticles-diethyldithiocarbamate using a co-spheroid 3D model of pancreatic cancer.
    J Gastroenterol. 2025 Jan 31. doi: 10.1007/s00535-025-02213.
    PubMed     Abstract available
    
    
    
12. IMAOKA H, Ikeda M, Kobayashi S, Ohba A, et al
    Correction: Efficacy of liposomal irinotecan + 5-FU/LV vs. S-1 in gemcitabine-refractory metastatic pancreatic cancer: a real-world study using inverse probability of treatment weighting.
    J Gastroenterol. 2025 Jan 29. doi: 10.1007/s00535-025-02215.
    PubMed    
    
    
    
13. HU K, Zhao X, Zhang N, Ma J, et al
    Effect of tumor microenvironment in pancreatic cancer on the loss of beta-cell mass: implications for type 3c diabetes.
    J Gastroenterol. 2025 Jan 6. doi: 10.1007/s00535-024-02204.
    PubMed     Abstract available
    
    
    December 2024
14. DEVASAHAYAM AROKIA BALAYA R, Sen P, Grant CW, Zenka R, et al
    An integrative multi-omics analysis reveals a multi-analyte signature of pancreatic ductal adenocarcinoma in serum.
    J Gastroenterol. 2024 Dec 12. doi: 10.1007/s00535-024-02197.
    PubMed     Abstract available
    
    
    
15. KUGIYAMA N, Nagaoka K, Yamada R, Watanabe T, et al
    Serum Mac2-binding protein glycosylated isomer (M2BPGi) as a prognostic biomarker in pancreatic ductal adenocarcinoma: iCAFs-derived M2BPGi drives tumor invasion.
    J Gastroenterol. 2024 Dec 11. doi: 10.1007/s00535-024-02195.
    PubMed     Abstract available
    
    
    
16. NOTOYA G, Kishikawa T, Yasugi K, Iwata T, et al
    WWP1 inhibition suppresses the proliferation of pancreatic cancer cells by regulating the PI3K-AKT pathway.
    J Gastroenterol. 2024 Dec 10. doi: 10.1007/s00535-024-02192.
    PubMed     Abstract available
    
    
    November 2024
17. IMAOKA H, Ikeda M, Kobayashi S, Ohba A, et al
    Efficacy of liposomal irinotecan + 5-FU/LV vs. S-1 in gemcitabine-refractory metastatic pancreatic cancer: a real-world study using inverse probability of treatment weighting.
    J Gastroenterol. 2024 Nov 30. doi: 10.1007/s00535-024-02186.
    PubMed     Abstract available
    
    
    
18. ISHIGAKI K, Tokito Y, Takahara N, Nishio H, et al
    Association between homologous recombination deficiency and time to treatment failure to platinum-based chemotherapy for pancreatic cancer by using the C-CAT database.
    J Gastroenterol. 2024 Nov 21. doi: 10.1007/s00535-024-02173.
    PubMed     Abstract available
    
    
    September 2024
19. MIKI M, Masuda A, Takenaka M, Shiomi H, et al
    Association of pancreatic atrophy patterns with intraductal extension of early pancreatic ductal adenocarcinoma: a multicenter retrospective study.
    J Gastroenterol. 2024 Sep 16. doi: 10.1007/s00535-024-02149.
    PubMed     Abstract available
    
    
    August 2024
20. WANG P, Huang B, Liu Y, Tan X, et al
    Corynoline protects chronic pancreatitis via binding to PSMA2 and alleviating pancreatic fibrosis.
    J Gastroenterol. 2024 Aug 15. doi: 10.1007/s00535-024-02145.
    PubMed     Abstract available
    
    
    June 2024
21. HIDAKA Y, Tanoue S, Ayukawa T, Takumi K, et al
    Impact of pancreatic ductal occlusion on postoperative outcomes in pancreatic head cancer patients undergoing neoadjuvant therapy.
    J Gastroenterol. 2024 Jun 20. doi: 10.1007/s00535-024-02125.
    PubMed     Abstract available
    
    
    
22. MINAGA K, Otsuka Y, Watanabe T
    High-mobility group box 1: friend or foe in pancreatitis.
    J Gastroenterol. 2024 Jun 17. doi: 10.1007/s00535-024-02123.
    PubMed    
    
    
    
23. ZHAO LJ, Chen P, Huang L, He WQ, et al
    Heparan sulfate acts as an activator of the NLRP3 inflammasome promoting inflammatory response in the development of acute pancreatitis.
    J Gastroenterol. 2024 Jun 12. doi: 10.1007/s00535-024-02127.
    PubMed     Abstract available
    
    
    May 2024
24. HOKKOKU D, Sasaki K, Kobayashi S, Shimbo T, et al
    High-mobility group box 1 fragment ameliorates chronic pancreatitis induced by caerulein in mice.
    J Gastroenterol. 2024 May 10. doi: 10.1007/s00535-024-02112.
    PubMed     Abstract available
    
    
    April 2024
25. MATSUMOTO K, Fujimori N, Ichihara K, Takeno A, et al
    Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction.
    J Gastroenterol. 2024 Apr 29. doi: 10.1007/s00535-024-02103.
    PubMed     Abstract available
    
    
    February 2024
26. NAGAO K, Sakai A, Tsumura H, Iemoto T, et al
    Pancreatic injury in patients treated with immune checkpoint inhibitors: a retrospective multicenterstudy.
    J Gastroenterol. 2024 Feb 29. doi: 10.1007/s00535-024-02083.
    PubMed     Abstract available
    
    
    January 2024
27. KASHIRO A, Kobayashi M, Oh T, Miyamoto M, et al
    Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of pancreatic cancer.
    J Gastroenterol. 2024 Jan 23. doi: 10.1007/s00535-023-02072.
    PubMed     Abstract available
    
    
    
28. ABE S, Masuda A, Matsumoto T, Inoue J, et al
    Impact of intratumoral microbiome on tumor immunity and prognosis in human pancreatic ductal adenocarcinoma.
    J Gastroenterol. 2024 Jan 20. doi: 10.1007/s00535-023-02069.
    PubMed     Abstract available
    
    
    November 2023
29. SAKAKIDA T, Ishikawa T, Doi T, Morita R, et al
    Genomic profile and clinical features of MSI-H and TMB-high pancreatic cancers: real-world data from C-CAT database.
    J Gastroenterol. 2023 Nov 25. doi: 10.1007/s00535-023-02058.
    PubMed     Abstract available
    
    
    
30. TAKEUCHI C, Sato J, Yamamichi N, Kageyama-Yahara N, et al
    Marked intestinal trans-differentiation by autoimmune gastritis along with ectopic pancreatic and pulmonary trans-differentiation.
    J Gastroenterol. 2023 Nov 14. doi: 10.1007/s00535-023-02055.
    PubMed     Abstract available
    
    
    September 2023
31. OZONO Y, Kawakami H, Uchiyama N, Hatada H, et al
    Current status and issues in genomic analysis using EUS-FNA/FNB specimens in hepatobiliary-pancreatic cancers.
    J Gastroenterol. 2023 Sep 12. doi: 10.1007/s00535-023-02037.
    PubMed     Abstract available
    
    
    
32. OKUSAKA T, Saiura A, Shimada K, Ikeda M, et al
    Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort.
    J Gastroenterol. 2023 Sep 7. doi: 10.1007/s00535-023-02033.
    PubMed     Abstract available
    
    
    August 2023
33. FISCHMAN M, Elias A, Klein A, Cohen Y, et al
    The association between phosphate level at admission and early mortality in acute pancreatitis.
    J Gastroenterol. 2023 Aug 18. doi: 10.1007/s00535-023-02034.
    PubMed     Abstract available
    
    
    July 2023
34. OYAMA H, Hamada T, Nakai Y, Tanaka M, et al
    Clinical trajectory of intraductal papillary mucinous neoplasms progressing to pancreatic carcinomas during long-term surveillance: a prospective series of 100 carcinoma cases.
    J Gastroenterol. 2023 Jul 29. doi: 10.1007/s00535-023-02028.
    PubMed     Abstract available
    
    
    
35. ASHINA S, Masuda A, Yamakawa K, Hamada T, et al
    A comprehensive analysis of tumor-stromal collagen in relation to pathological, molecular, and immune characteristics and patient survival in pancreatic ductal adenocarcinoma.
    J Gastroenterol. 2023 Jul 21. doi: 10.1007/s00535-023-02020.
    PubMed     Abstract available
    
    
    June 2023
36. TOMIMARU Y, Eguchi H, Shimomura Y, Kitamura T, et al
    Standard versus delayed initiation of S-1 adjuvant chemotherapy after surgery for pancreatic cancer: a secondary analysis of a nationwide cohort by the Japan Pancreas Society.
    J Gastroenterol. 2023 Jun 17. doi: 10.1007/s00535-023-01988.
    PubMed     Abstract available
    
    
    May 2023
37. KAWASAKI Y, Hijioka S, Nagashio Y, Maruki Y, et al
    Efficacy of endoscopic ultrasound-guided tissue acquisition for solid pancreatic lesions 20 mm or less in diameter suspected as neuroendocrine tumors or requiring differentiation.
    J Gastroenterol. 2023 May 8. doi: 10.1007/s00535-023-01995.
    PubMed     Abstract available
    
    
    April 2023
38. SAKAI A, Masuda A, Kodama Y
    Does early intervention for infected pancreatic necrosis lead to better clinical outcomes compared to delayed intervention?
    J Gastroenterol. 2023 Apr 30. doi: 10.1007/s00535-023-01994.
    PubMed    
    
    
    
39. MURAKAMI M, Fujimori N, Nakata K, Nakamura M, et al
    Machine learning-based model for prediction and feature analysis of recurrence in pancreatic neuroendocrine tumors G1/G2.
    J Gastroenterol. 2023 Apr 26. doi: 10.1007/s00535-023-01987.
    PubMed     Abstract available
    
    
    
40. SAKAKIDA T, Ishikawa T, Doi T, Morita R, et al
    Genomic landscape and clinical features of rare subtypes of pancreatic cancer: analysis with the national database of Japan.
    J Gastroenterol. 2023 Apr 7. doi: 10.1007/s00535-023-01986.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pancreatitis is free of charge.